olomoucine and Inflammation

olomoucine has been researched along with Inflammation in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hsieh, CC; Jhou, RS; Lin, TI; Liu, HY; Lu, SY; Sun, GH; Sun, KH; Tang, SJ; Tsou, YC; Wang, HH	1
Chang, CI; Huang, HC; Jhou, RS; Lu, SY; Sun, GH; Sun, KH; Tang, SJ; Wang, HH	1

Other Studies

2 other study(ies) available for olomoucine and Inflammation

Article	Year
Down-regulation of BNIP3 by olomoucine, a CDK inhibitor, reduces LPS- and NO-induced cell death in BV2 microglial cells. Neuroscience letters, 2016, 08-15, Volume: 628 Topics: Animals; Apoptosis; Cell Line; Cell Proliferation; Cyclin-Dependent Kinases; Down-Regulation; E2F Transcription Factors; Enzyme Inhibitors; Inflammation; Inflammation Mediators; Kinetin; Lipopolysaccharides; Membrane Proteins; Mice; Microglia; Mitochondria; Mitochondrial Proteins; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II	2016
Inhibition of cyclin-dependent kinases by olomoucine and roscovitine reduces lipopolysaccharide-induced inflammatory responses via down-regulation of nuclear factor kappaB. Cell proliferation, 2009, Volume: 42, Issue:2 Topics: Animals; Cell Line, Tumor; Cyclin-Dependent Kinases; Down-Regulation; E2F1 Transcription Factor; Enzyme Inhibitors; Gene Expression; Inflammation; Interleukin-1alpha; Interleukin-6; Kinetin; Lipopolysaccharides; Macrophages; Mice; Models, Biological; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Promoter Regions, Genetic; Purines; RNA Interference; Roscovitine; Transcription Factor RelA; Tumor Necrosis Factor-alpha	2009

Article

Year

Down-regulation of BNIP3 by olomoucine, a CDK inhibitor, reduces LPS- and NO-induced cell death in BV2 microglial cells.

Neuroscience letters, 2016, 08-15, Volume: 628

Topics: Animals; Apoptosis; Cell Line; Cell Proliferation; Cyclin-Dependent Kinases; Down-Regulation; E2F Transcription Factors; Enzyme Inhibitors; Inflammation; Inflammation Mediators; Kinetin; Lipopolysaccharides; Membrane Proteins; Mice; Microglia; Mitochondria; Mitochondrial Proteins; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II

2016

Inhibition of cyclin-dependent kinases by olomoucine and roscovitine reduces lipopolysaccharide-induced inflammatory responses via down-regulation of nuclear factor kappaB.

Cell proliferation, 2009, Volume: 42, Issue:2

Topics: Animals; Cell Line, Tumor; Cyclin-Dependent Kinases; Down-Regulation; E2F1 Transcription Factor; Enzyme Inhibitors; Gene Expression; Inflammation; Interleukin-1alpha; Interleukin-6; Kinetin; Lipopolysaccharides; Macrophages; Mice; Models, Biological; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Promoter Regions, Genetic; Purines; RNA Interference; Roscovitine; Transcription Factor RelA; Tumor Necrosis Factor-alpha

2009